Related Experiment Videos
Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide
F J Jiménez-Jiménez1, J López-Alvarez, M Sánchez-Chapado
1Department of Neurology, Hospital Príncipe de Asturias, Alcalá de Henares (Madrid), Spain.
Clinical Neuropharmacology
|June 1, 1995
Abstract:
We describe a 68-year-old patient with Parkinson's disease who developed retroperitoneal fibrosis during pergolide treatment. Because pergolide is an ergot derivative, it could be related to the development of this complication.